These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24198725)

  • 1. Design, development, and optimization of polymeric based-colonic drug delivery system of naproxen.
    Sharma P; Chawla A; Pawar P
    ScientificWorldJournal; 2013; 2013():654829. PubMed ID: 24198725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system.
    Mehta R; Chawla A; Sharma P; Pawar P
    J Adv Pharm Technol Res; 2013 Jan; 4(1):31-41. PubMed ID: 23662280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
    Ibekwe VC; Fadda HM; Parsons GE; Basit AW
    Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
    Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
    Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a potential colonic drug delivery system of mesalamine.
    Gohel MC; Parikh RK; Nagori SA; Dabhi MR
    Pharm Dev Technol; 2008; 13(5):447-56. PubMed ID: 18798122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease.
    Leopold CS; Eikeler D
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1239-46. PubMed ID: 11147124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pH-dependent colon-targeted oral drug delivery system using methacrylic acid copolymers. II. Manipulation of drug release using Eudragit L100 and Eudragit S100 combinations.
    Khan MZ; Stedul HP; Kurjaković N
    Drug Dev Ind Pharm; 2000 May; 26(5):549-54. PubMed ID: 10789067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
    Vemula SK
    Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pH-dependent colon targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation Of drug release using Eudragit L100-55 and Eudragit S100 combinations.
    Khan MZ; Prebeg Z; Kurjaković N
    J Control Release; 1999 Mar; 58(2):215-22. PubMed ID: 10053194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
    Jadiya S; Upmanyu N; Sathiyanarayanan A; Jain V; Dubey R; Buwade P
    J Pharm Sci; 2024 Jul; 113(7):1919-1926. PubMed ID: 38401631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55.
    Zaghloul AA; Vaithiyalingam SR; Faltinek J; Reddy IK; Khan MA
    J Microencapsul; 2001; 18(5):651-62. PubMed ID: 11508770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of enteric-coated timed-release matrix tablets for colon targeting.
    Alvarez-Fuentes J; Fernández-Arévalo M; González-Rodríguez ML; Cirri M; Mura P
    J Drug Target; 2004; 12(9-10):607-12. PubMed ID: 15621686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.